Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes
Open Access
- 1 September 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 30 (3) , 730-739
- https://doi.org/10.1002/hep.510300332
Abstract
We examined the effects of the administration of different bile acids on in vivo hepatic murine cytochrome P450 (CYP) content, nicotinamide adenine dinucleotide phosphate (NADPH)-CYP-reductase, and individual mixed-function oxidases (MFOs). Neither CYP level nor reductase were appreciably affected by single intraperitoneal administration of taurodeoxycholic acid (TDCA) (12.2 or 24.4 mg × kg−1 bw). MFO to various isoenzymes were slightly reduced 24 hours after treatment. Taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) both induced CYP, reductase, and MFOs. CYP3A1/2-linked activity (i.e., testosterone 6β-hydroxylase, and N-demethylation of aminopyrine) in a dose-dependent fashion was enhanced (˜2-3-fold). CYP2E1- (hydroxylation of p-nitrophenol), CYP1A2-(O-demethylation of methoxyresorufin), CYP2A1/2- and CYP2B1/2-(6α-hydroxylase), and CYP2B9- (16α-hydroxylase) dependent MFOs, as well as 7α-, 16β-, 2α-, and 2β-hydroxylations, were all significantly induced by THDCA. Apart from alkoxyresorufin metabolism and a modest CYP2E1 increase, TUDCA behaved like THDCA. A generalized induction was also recorded after ursodeoxycholic acid (UDCA) administration. THDCA and TDCA did not show substantial differences in the N-demethylation of aminopyrine when different species (rat vs. mouse) and administration route (intraperitoneal vs. intravenous) were compared. Results on the most affected isoenzymes, CYP3A1/2 (THDCA, TUDCA, and UDCA) and CYP2E1 (UDCA), were sustained by means of Western immunoblotting. CYP3A induction was paralleled by a corresponding increase in mRNA. These data could partially explain the therapeutic mechanism of UDCA, TUDCA, and THDCA in chronic cholestatic liver disease. CYP3A induction, which is linked to P-glycoprotein (Pgp) family overexpression, may enhance hepatic metabolism, transport, and excretion of toxic endogenous lipophilic bile acids.Keywords
This publication has 53 references indexed in Scilit:
- Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the ratHepatology, 1998
- Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: Relevance to drug metabolism in experimental cholestasisJournal of Gastroenterology and Hepatology, 1996
- Tauro α-muricholate is as effective as tauro β-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the ratHepatology, 1994
- Tauro β-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the ratLife Sciences, 1990
- Correlation between the biliary excretion of ouabain and the lateral mobility of hepatocyte plasma membrane proteins in the rat—the effects of age and spironolactone pretreatmentHepatology, 1988
- Reduced synthesis of hepatic microsomal cytochrome P450 in the bile duct ligated ratBiochemical and Biophysical Research Communications, 1974
- Turnover of hepatic cytochrome P-450 in experimental cholestasisExperimental and Molecular Pathology, 1973
- Mechanism of CholestasisGastroenterology, 1971
- Mechanism of cholestasis. 2. Effect of bile acids on the microsomal electron transfer systemLife Sciences, 1970
- Mechanism of cholestasis. 1. Effect of bile acids on microsomal cytochrome P-450 dependent biotransformation systemLife Sciences, 1970